163 related articles for article (PubMed ID: 1428967)
21. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
22. [A case of serous surface papillary carcinoma of the peritoneum metastatic to the brain].
Sakakibara Y; Endo S; Yoshida Y; Tanaka Y; Hashimoto T; Ohara T
No Shinkei Geka; 2011 Jun; 39(6):607-10. PubMed ID: 21628741
[TBL] [Abstract][Full Text] [Related]
23. [Peritoneal papillary serous carcinoma in a patient with previous surgery for breast cancer: clinical case].
Amanti C; Lombardi A; Moscaroli A; Catracchia V; Lo Russo M; Marino G; Conte S; Provenza G
G Chir; 2006; 27(1-2):45-8. PubMed ID: 16608633
[TBL] [Abstract][Full Text] [Related]
24. Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin.
Le TD; Yamada SD; Rutgers JL; DiSaia PJ
Gynecol Oncol; 1999 Jun; 73(3):461-3. PubMed ID: 10366480
[TBL] [Abstract][Full Text] [Related]
25. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
26. [Primary, papillary serous carcinoma of the peritoneum; a report of experiences].
Petru E; Heydarfadai M; Pickel H; Lahousen M; Tamussino K
Geburtshilfe Frauenheilkd; 1992 Sep; 52(9):533-5. PubMed ID: 1397954
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy in uterine papillary serous carcinoma.
Resnik E; Taxy JB
Gynecol Oncol; 1996 Jul; 62(1):123-7. PubMed ID: 8690284
[TBL] [Abstract][Full Text] [Related]
28. Serous surface papillary carcinoma of the peritoneum: clinical, radiologic, and pathologic findings in 11 patients.
Morita H; Aoki J; Taketomi A; Sato N; Endo K
AJR Am J Roentgenol; 2004 Oct; 183(4):923-8. PubMed ID: 15385282
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
30. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
Schmeler KM; Sun CC; Bodurka DC; Deavers MT; Malpica A; Coleman RL; Ramirez PT; Gershenson DM
Gynecol Oncol; 2008 Mar; 108(3):510-4. PubMed ID: 18155273
[TBL] [Abstract][Full Text] [Related]
32. [A case of malignant peritoneal mesothelioma successfully treated with carboplatin and paclitaxel].
Ogura O; Noguchi T; Nagata K; Noma H; Maemura M; Higashimoto M; Takebayashi Y; Maeda S
Gan To Kagaku Ryoho; 2006 Jul; 33(7):1001-4. PubMed ID: 16835497
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
34. Serous surface papillary carcinoma. A clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma.
Mills SE; Andersen WA; Fechner RE; Austin MB
Am J Surg Pathol; 1988 Nov; 12(11):827-34. PubMed ID: 3189692
[TBL] [Abstract][Full Text] [Related]
35. Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum.
Kennedy AW; Markman M; Webster KD; Kulp B; Peterson G; Rybicki LA; Belinson JL
Gynecol Oncol; 1998 Nov; 71(2):288-90. PubMed ID: 9826473
[TBL] [Abstract][Full Text] [Related]
36. Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.
Chambers JT; Chambers SK; Kohorn EI; Carcangiu ML; Schwartz PE
Gynecol Oncol; 1996 Mar; 60(3):438-42. PubMed ID: 8774654
[TBL] [Abstract][Full Text] [Related]
37. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
38. Extraovarian peritoneal serous papillary carcinoma: a case report.
Veroni S; Terzopoulou K; Anagnostopoulou I; Vassilakaki T; Grammatoglou X; Rammou R
Acta Cytol; 2010; 54(5 Suppl):879-84. PubMed ID: 21053561
[TBL] [Abstract][Full Text] [Related]
39. High-grade primary peritoneal serous papillary carcinoma with a wide differential diagnosis: a diagnostic challenge.
Gilani S; Tashjian R; Fathallah L
Pathologica; 2012 Dec; 104(6):442-5. PubMed ID: 23547430
[TBL] [Abstract][Full Text] [Related]
40. [A case of malignant peritoneal mesothelioma successfully treated with concurrent chemoradiotherapy].
Hida K; Hashimoto K; Ishitani K; Maebayashi K; Mitsuhashi N; Matsui H
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2639-41. PubMed ID: 22189233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
